by AIP Online Bureau | Jan 26, 2024 | Eco/Invest/Demography, International News, Regulation, Risk Management
US Attorney Damian Williams highlighted that proof has been found that Dagar stole information about Paxlovid from his employer, Pfizer, and used that illegal edge to profit in the stock market Indian-American former Pfizer Inc. employee, Amit Dagar, who was charged...
by AIP Online Bureau | Dec 2, 2023 | Eco/Invest/Demography, Health, International News, Pandemic, Risk Management
“Pfizer intentionally misrepresented the efficacy of its COVID-19 vaccine and censored persons who threatened to disseminate the truth in order to facilitate fast adoption of the product and expand its commercial opportunity,” the complaint said Pfizer has...
by AIP Online Bureau | Jan 14, 2023 | Health, International News, Non-Life
Investigation of the signal raised a question of whether people 65 and older who received the Pfizer-BioNTech bivalent shot were more likely to have an ischemic stroke, a loss of blood flow in the brain, in the 21 days following vaccination compared with days 22-44...
by AIP Online Bureau | Jan 8, 2023 | Health, International News, Non-Life, Pandemic, Policy
Boxes of Paxlovid are changing hands for as much as 50,000 yuan ($7,313.15), more than 20 times the original price of 2,300 yuan, according to local media reports and social media posts. Beijing has been largely resistant to Western vaccines, but has greenlighted...
by AIP Online Bureau | Aug 26, 2022 | Eco/Invest/Demography, International News, Non-Life, Reinsurance, Risk Management
Early in the pandemic, Moderna said it would not enforce its COVID-19 patents to help others develop their own vaccines, particularly for low- and middle-income countries. But in March 2022 Moderna said it expected companies such as Pfizer and BioNTech to respect its...
